Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-186940
Filing Date
2026-04-28
Accepted
2026-04-28 16:06:10
Documents
11

Document Format Files

Seq Description Document Type Size
1 DEFA14A bolt-20260427.htm   iXBRL DEFA14A 26762
2 GRAPHIC img119940086_0.jpg GRAPHIC 329667
3 GRAPHIC img119940086_1.jpg GRAPHIC 147240
  Complete submission text file 0001193125-26-186940.txt   1342432

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20260427.xsd EX-101.SCH 7383
14 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20260427_htm.xml XML 1303
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39988 | Film No.: 26907621
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)